deltatrials
Completed OBSERVATIONAL NCT02758808

Pulmonary Fibrosis Foundation Patient Registry (PFFR)

Sponsor: Pulmonary Fibrosis Foundation

Updated 20 times since 2017 Last updated: Jul 5, 2023 Started: Mar 29, 2016 Primary completion: Dec 16, 2022 Completion: Dec 16, 2022
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT02758808, this observational or N/A phase trial focuses on Idiopathic Pulmonary Fibrosis (IPF) and Interstitial Lung Disease (ILD) and remains completed. Sponsored by Pulmonary Fibrosis Foundation, it has been updated 20 times since 2016, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

~Jan 2017 – ~Aug 2017 · 7 months · monthly snapshot~Aug 2017 – ~Dec 2017 · 4 months · monthly snapshot~Dec 2017 – ~Apr 2018 · 4 months · monthly snapshot~Apr 2018 – ~May 2018 · 30 days · monthly snapshot~May 2018 – ~Jun 2018 · 31 days · monthly snapshot~Jun 2018 – ~Jan 2019 · 7 months · monthly snapshot~Jan 2019 – ~Oct 2019 · 9 months · monthly snapshot~Oct 2019 – ~Aug 2020 · 10 months · monthly snapshot~Aug 2020 – ~Oct 2020 · 2 months · monthly snapshot~Oct 2020 – ~Nov 2020 · 31 days · monthly snapshot~Nov 2020 – ~Jan 2021 · 2 months · monthly snapshot~Jan 2021 – ~Sep 2021 · 8 months · monthly snapshot~Sep 2021 – ~Dec 2021 · 3 months · monthly snapshot~Dec 2021 – ~Jan 2022 · 31 days · monthly snapshot~Jan 2022 – ~Sep 2022 · 8 months · monthly snapshot~Sep 2022 – ~Aug 2023 · 11 months · monthly snapshot~Aug 2023 – ~Jul 2024 · 11 months · monthly snapshot~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – ~Sep 2025 · 12 months · monthly snapshot~Sep 2025 – present · 12 months · monthly snapshot

Change History

20 versions recorded
  1. Sep 2025 — Present [monthly]

    Completed

  2. Sep 2024 — Sep 2025 [monthly]

    Completed

  3. Jul 2024 — Sep 2024 [monthly]

    Completed

  4. Aug 2023 — Jul 2024 [monthly]

    Completed

    Status: Active Not RecruitingCompleted

  5. Sep 2022 — Aug 2023 [monthly]

    Active Not Recruiting

Show 15 earlier versions
  1. Jan 2022 — Sep 2022 [monthly]

    Active Not Recruiting

    Status: RecruitingActive Not Recruiting

  2. Dec 2021 — Jan 2022 [monthly]

    Recruiting

  3. Sep 2021 — Dec 2021 [monthly]

    Recruiting

  4. Jan 2021 — Sep 2021 [monthly]

    Recruiting

  5. Nov 2020 — Jan 2021 [monthly]

    Recruiting

  6. Oct 2020 — Nov 2020 [monthly]

    Recruiting

  7. Aug 2020 — Oct 2020 [monthly]

    Recruiting

  8. Oct 2019 — Aug 2020 [monthly]

    Recruiting

  9. Jan 2019 — Oct 2019 [monthly]

    Recruiting

  10. Jun 2018 — Jan 2019 [monthly]

    Recruiting

  11. May 2018 — Jun 2018 [monthly]

    Recruiting

  12. Apr 2018 — May 2018 [monthly]

    Recruiting

    Phase: NANone

  13. Dec 2017 — Apr 2018 [monthly]

    Recruiting NA

  14. Aug 2017 — Dec 2017 [monthly]

    Recruiting NA

  15. Jan 2017 — Aug 2017 [monthly]

    Recruiting NA

    First recorded

Mar 2016

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Pulmonary Fibrosis Foundation
  • University of Michigan
Data source: Pulmonary Fibrosis Foundation

For direct contact, visit the study record on ClinicalTrials.gov .